Sequencing of FLT3-mutated R/R-AML samples revealed the acquisition of mutations in alternative genes aside from RAS/MAPK pathway regulators including IDH1, WT1, RUNX1, ASXL1, SF3B1, U2AF1, and ZBTB7A [40]. The gene discussed is FLT3; the disease is acute myeloid leukemia.